NEJM Journal Watch accepts advertising and sponsorship for its website and related
e-mail services (e-mail alerts) according to the following principles:
Advertising is separate from content. Advertisers and sponsors have no advance
knowledge of our editorial content, nor do the editors have advance knowledge
of advertisers. Content is never altered, added, or deleted to accommodate advertising.
Advertisers and sponsors have no input regarding any of our editorial decisions
or advertising policies. The advertising sales representatives have neither
control over, nor prior knowledge of, specific editorial content before it is
NEJM Journal Watch reserves the right to decline or cancel any advertisement
at any time.
Advertising must be factual and in good taste in the judgment of the MMS. Please
note: Readers who click on an advertising banner or other advertising link may
connect to a site different from NEJM Journal Watch Journal Watch to view additional
information. Such sites may also ask visitors for additional data. NEJM Journal
Watch does not participate in, nor control such sites.
Third-party advertisements on NEJM Journal Watch or the e-mail alerts may not
include any Massachusetts Medical Society or NEJM Journal Watch publication
name, logo, or title.
Advertised products must be compliant with the regulations in the country where
the advertisement will be seen. Advertisements for pharmaceutical products (including
new drug applications) that are subject to U.S. Food and Drug Administration
oversight must comply with FDA regulations regarding advertising and promotion.
Users will be able to distinguish advertising and editorial content clearly
on the website and in e-mail alerts.
NEJM Journal Watch does not endorse any company, product, or service appearing
in its advertising.
Advertisers and sponsors have no control or influence over the results of searches
a user may conduct on NEJM Journal Watch. Search results are based solely on
the functionality available through our search software (e.g., keywords or natural
language) and user-defined criteria (e.g., displaying most recent or most relevant
Updates to our Internet advertising policy will be posted to this website.
Types of Advertising
GENERALLY ACCEPTABLE FOR CONSIDERATION
Pharmaceutical products; medical-equipment products and services; medical software;
practice-management products and services (including office equipment and supplies,
medical billing systems, medical software products) and medical websites.
GENERALLY ACCEPTABLE FOR CONSIDERATION WITH CERTAIN CONDITIONS
Calls for patients to participate in clinical trials, or clinical-trial matching
services will be considered solely if the trial is conducted by a recognized
academic institution. All types of advertising not described above will be reviewed
on a case-by-case basis.
Distribution of some NEJM Journal Watch print and electronic issues is supported
by sponsorship. Sponsorship and editorial content are clearly separated. A link
to the Electronic Advertising Policy will appear with all sponsorship on the
website and in the e-mail alerts. Acknowledgment of support will not make any
claims for any supporting company's product(s). The final wording and position
of the acknowledgments will be determined by NEJM Journal Watch.
USERS´ PERSONAL INFORMATION
NEJM Journal Watch does not release personally identifiable data on users of
our website or e-mail alerts to advertisers. See also the NEJM Journal Watch
Advertisers on NEJM Journal Watch may receive reports that provide aggregated
data about the response to their advertisements. Such data may include:
The number of impressions (the number of times the advertisement has been viewed
on the website);
The number and/or percentage of impressions that accounted for a click-through
to a different site (click-through rate);
The percentage of registered vs. nonregistered users who viewed the advertisement;
Aggregated demographic data about users who viewed the advertisement.
This information will be disclosed in the aggregate only — for example, "physicians
with a specialty of cardiology accounted for 30 percent of all e-mail alert
recipients with this advertisement."